The CRISTALLO trial showed that venetoclax plus obinutuzumab achieved high minimal residual disease negativity as a frontline ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a ...

During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...

A new international study has found that a simple tablet treatment could improve survival rates for people with chronic ...